1. Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA (1987) 6-Hydroxydopamine treatments enhance behavioral response to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. J Pharmacol Exp Ther 240:167–176
2. Bürki HR, Ruch W, Asper H (1975) Effects of clozapine, thioridazine, perlapine and haloperidol on the metabolism of the biogenic amines in the brain of the rat. Psychopharmacologia 41:27–33
3. Clow A, Jenner P, Marsden CD (1979) Changes of dopamine-mediated behaviour during one year's neuroleptic administration. Eur J Pharmacol 57:135–144
4. Cools AR (1980) Rapid development of hypersensitivity to apomorphine and haloperidol: role of norepinephrine receptor mechanisms in the CNS. In: Cattabeni F, Racagni G, Spano PF, Costa E (eds) Long-term effects of neuroleptics. Adv Biochem Pharmacol 24. Raven Press, New York, pp 215–225
5. Costall B, Fortune DH, Naylor RJ, Nohria V (1979) A study of drug action on normal and striatal denervated mechanisms. Eur J Pharmacol 56:207–216